Last reviewed · How we verify
Use of MEOPA during suturing — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Use of MEOPA during suturing (Use of MEOPA during suturing) — Centre Hospitalier Universitaire de Nīmes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Use of MEOPA during suturing TARGET | Use of MEOPA during suturing | Centre Hospitalier Universitaire de Nīmes | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Use of MEOPA during suturing CI watch — RSS
- Use of MEOPA during suturing CI watch — Atom
- Use of MEOPA during suturing CI watch — JSON
- Use of MEOPA during suturing alone — RSS
Cite this brief
Drug Landscape (2026). Use of MEOPA during suturing — Competitive Intelligence Brief. https://druglandscape.com/ci/use-of-meopa-during-suturing. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab